ITMCTR2000003055RecruitingPhase 1
Clinical study of guanxining tablet in the treatment of rheumatoid arthritis with cardiovascular damage
Zhejinag University of f Chinese Medicine0 sitesStarted: TBDLast updated:
Conditions
Trial Snapshot
- Phase
- Phase 1
- Status
- Recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional study
Eligibility Criteria
- Sex
- All
Inclusion Criteria
- •(1) meet the diagnostic criteria of RA, activity period and abnormal heart function;
- •(2) between the ages of 18 and 60;
- •(3) if taking NSAIDs, the dose has been stable for at least 4 weeks; if not, it has been stable for at least 1 week;
- •(4) if you take MTX, you have been treated with MTX3 for at least 4 months, and the dose is fixed at 10mg/ week for at least 4 weeks.If you take LEF, you have been treated with leff for at least 3 months, and the dose is fixed at 10mg/ day for at least 4 weeks.
- •(5) if glucocorticoid is taken, the dose (compared with prednisone) must be less than 15mg/ day and has been used for at least 4 weeks;
- •(6) participate in the study voluntarily and sign the informed consent.
Exclusion Criteria
- •(1) intramuscular injection or intravenous drip of glucocorticoids within 4 weeks;
- •(2) das28-3 score > 5.1 (high activity);
- •(3) patients with other rheumatic diseases such as systemic lupus erythematosus, sjogren's syndrome and gout;
- •(4) pregnant or nursing women or those who plan to give birth in the near future;
- •(5) allergic to the test drugs;
- •(6) those who have participated in other clinical trials recently (within 1 month);
- •(7) mental patients and people without capacity for civil conduct.
Investigators
Similar Trials
Recruiting
Phase 1
Clinical efficacy evaluation of Guanxinning tablet in the prevention and treatment of hypertension and Coronary heart disease complicated with heart failurehypertension and Coronary heart disease complicated with heart failureITMCTR2100005201Shenzhen Luohu People's Hospital
Not yet recruiting
Phase 4
Effectiveness of Guanxinning Tablet on the Stable Coronary Artery Disease based on the Real World: A Multi-center Registration StudyITMCTR1900025340Xiyuan Hospital, CACMS
Not yet recruiting
Phase 4
Evaluation of the clinical efficacy of Guanxinning tablets in the treatment of patients with carotid atherosclerotic plaqueCarotid atherosclerotic plaque formationITMCTR2100005440Dongzhimen Hospital, Beijing University of Chinese Medicine
Recruiting
Phase 4
Clinical Study for Tongmai Yangxin Pill in Treating Premature Atrial Contraction With Qi and Yin Deficiency SyndromePremature atrial contractionITMCTR1900002579The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine
Not yet recruiting
Phase 4
Clinical Study of Tongmai Yangxin Pill in Treating Slow Arrhythmia (Qi-Yin Deficiency Syndrome)ITMCTR1900002578The Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine